연구성과로 돌아가기
2025 연구성과별 연구자 정보 (1137 / 1187)
※ 현재 Web of Science 저자 정보만 집계되어 있습니다.
※ 컨트롤 + 클릭으로 열별 다중 정렬 가능합니다.
Excel 다운로드
| Document Title | Author Full Name | Author Short Name | Index | Corresponding | Address | ResearcherID | ResearcherID Author Name | ORCID | ORCID Author Name | Related Email |
|---|---|---|---|---|---|---|---|---|---|---|
| Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study | Robert, G. | Robert, G | 26 | Mater Hosp, Gastroenterol, Brisbane, Australia | ||||||
| Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study | Vasudevan, A. | Vasudevan, A | 27 | Eastern Hlth, Gastroenterol, Melbourne, Australia | ||||||
| Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study | Zhang, J. | Zhang, J | 28 | Eastern Hlth, Gastroenterol, Melbourne, Australia | ||||||
| Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study | Brownson, A. | Brownson, A | 29 | Te Whatu Ora Southern Dunedin Hosp, Gastroenterol, Dunedin, New Zealand | ||||||
| Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study | Ngoi, B. | Ngoi, B | 30 | Royal Adelaide Hosp, Gastroenterol, Adelaide, Australia | ||||||
| Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study | Kate, L. | Kate, L | 31 | Royal Adelaide Hosp, Gastroenterol, Adelaide, Australia | ||||||
| Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study | Haifer, C. | Haifer, C | 32 | St Vincents Hosp Sydney, Gastroenterol, Sydney, Australia | ||||||
| Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study | Bracken, L. M. L. | Bracken, LML | 33 | St Vincents Hosp Sydney, Gastroenterol, Sydney, Australia | ||||||
| Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study | Swe, E. | Swe, E | 34 | Townsville Univ Hosp, Gastroenterol, Townsville, NC USA | ||||||
| Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study | Wright, E. | Wright, E | 35 | St Vincents Hosp Melbourne, Gastroenterol, Melbourne, Australia | ||||||
| Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study | Clark, N. | Clark, N | 36 | St Vincents Hosp Melbourne, Gastroenterol, Melbourne, Australia | ||||||
| Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study | Schildkraut, T. | Schildkraut, T | 37 | St Vincents Hosp Melbourne, Gastroenterol, Melbourne, Australia | ||||||
| Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study | Mahy, G. | Mahy, G | 38 | Townsville Univ Hosp, Gastroenterol, Townsville, NC USA | ||||||
| Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study | Moore, G. | Moore, G | 39 | Monash Hlth, Melbourne, Australia | ||||||
| Uncontrolled clinical activity and anti-TNF plus thiopurine combination therapy are predictive factors of 1-year infection risk following acute severe ulcerative colitis: AOCC and ANZIBDC collaboration study | Moore, G. | Moore, G | 39 | Monash Univ, Gastroenterol, Melbourne, Australia |
페이지 이동: